D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 104 Citations 38,105 387 World Ranking 3117 National Ranking 124

Research.com Recognitions

Awards & Achievements

1996 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are Cancer research, Internal medicine, Pathology, Oncology and Medulloblastoma. His Cancer research research integrates issues from Wnt signaling pathway, Signal transduction, Mutation, Molecular biology and Tumor suppressor gene. Torsten Pietsch studied Internal medicine and Surgery that intersect with O-6-methylguanine-DNA methyltransferase.

His Pathology research includes elements of Neuropil and Gene expression, DNA methylation. His study in Oncology is interdisciplinary in nature, drawing from both Glioblastoma, Cancer, Cohort and Glioma. His studies in Medulloblastoma integrate themes in fields like Clinical trial, Bioinformatics, Gene expression profiling, Immunology and Meta-analysis.

His most cited work include:

  • Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors (846 citations)
  • Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. (760 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Pathology, Cancer research, Oncology and Medulloblastoma. His Internal medicine study integrates concerns from other disciplines, such as Surgery and Glioma. His Central nervous system research extends to the thematically linked field of Pathology.

His Cancer research research incorporates elements of Mutation, Methylation, Gene, DNA methylation and Tumor suppressor gene. His research integrates issues of Cancer, Clinical trial, Cohort and Hazard ratio in his study of Oncology. His research brings together the fields of Bioinformatics and Medulloblastoma.

He most often published in these fields:

  • Internal medicine (29.42%)
  • Pathology (28.12%)
  • Cancer research (26.63%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (29.42%)
  • Cancer research (26.63%)
  • Oncology (23.09%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Cancer research, Oncology, Ependymoma and Chemotherapy are his primary areas of study. His Internal medicine study combines topics in areas such as Gastroenterology and Medulloblastoma. The concepts of his Medulloblastoma study are interwoven with issues in Retrospective cohort study and Non metastatic.

Torsten Pietsch combines subjects such as Methylation and DNA with his study of Cancer research. His Oncology research is multidisciplinary, incorporating perspectives in Cancer, Clinical trial, Proportional hazards model and Hazard ratio. His Ependymoma research is included under the broader classification of Pathology.

Between 2018 and 2021, his most popular works were:

  • Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial (127 citations)
  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
  • Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes (30 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Torsten Pietsch focuses on Cancer research, Internal medicine, Oncology, Pathology and Ependymoma. His work in the fields of Cancer research, such as Glioblastoma, overlaps with other areas such as Ceritinib. His work deals with themes such as Target expression and Glioma, which intersect with Internal medicine.

His biological study spans a wide range of topics, including Temozolomide, Recurrent glioblastoma, Monoclonal antibody and Hazard ratio. His Pathology study combines topics from a wide range of disciplines, such as Tumor progression and Neuroepithelial cell. His work in DNA methylation tackles topics such as Germline which are related to areas like Medulloblastoma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.

Walter Stummer;Hanns-Jürgen Reulen;Thomas Meinel;Uwe Pichlmeier.
Neurosurgery (2008)

1187 Citations

Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors

Barbara Lustig;Boris Jerchow;Martin Sachs;Sigrid Weiler.
Molecular and Cellular Biology (2002)

1058 Citations

Long-term survival with glioblastoma multiforme

Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling.
Brain (2007)

891 Citations

DNA methylation-based classification of central nervous system tumours

David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Nature (2018)

860 Citations

NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

Wolfgang Wick;Christian Hartmann;Corinna Engel;Mandy Stoffels.
Journal of Clinical Oncology (2009)

859 Citations

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

Marcel Kool;Andrey Korshunov;Marc Remke;Marc Remke;David T.W. Jones.
Acta Neuropathologica (2012)

845 Citations

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas

Christian Hartmann;Christian Hartmann;Bettina Hentschel;Wolfgang Wick;Wolfgang Wick;David Capper.
Acta Neuropathologica (2010)

843 Citations

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge.
Lancet Oncology (2014)

791 Citations

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

Stefan Rutkowski;Udo Bode;Frank Deinlein;Holger Ottensmeier.
The New England Journal of Medicine (2005)

739 Citations

Treatment of brain tumors

Arnold C. Paulino;Bin S. Teh;Michelle Sadeh;Lynn Ashby.
The New England Journal of Medicine (2005)

736 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Torsten Pietsch

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 461

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 285

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 239

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 223

Michael Weller

Michael Weller

University of Zurich

Publications: 207

Marcel Kool

Marcel Kool

German Cancer Research Center

Publications: 178

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 175

David Capper

David Capper

Humboldt-Universität zu Berlin

Publications: 175

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 166

Eric Bouffet

Eric Bouffet

University of Toronto

Publications: 136

Cynthia Hawkins

Cynthia Hawkins

University of Toronto

Publications: 114

Paul A. Northcott

Paul A. Northcott

St. Jude Children's Research Hospital

Publications: 113

Arie Perry

Arie Perry

University of California, San Francisco

Publications: 109

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Publications: 108

Charles G. Eberhart

Charles G. Eberhart

Johns Hopkins University School of Medicine

Publications: 107

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 102

Something went wrong. Please try again later.